Nanalysis Scientific Corp.
NSCIF
$0.2215
$0.01175.58%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.21M | -1.46M | -1.87M | -1.99M | -4.69M |
| Total Depreciation and Amortization | 347.50K | 344.90K | 356.80K | 325.60K | 844.70K |
| Total Amortization of Deferred Charges | 506.60K | 498.40K | 497.70K | 476.30K | -- |
| Total Other Non-Cash Items | 689.20K | 765.90K | 666.10K | 612.30K | 3.26M |
| Change in Net Operating Assets | -574.80K | 619.70K | 1.44M | -1.14M | -422.00K |
| Cash from Operations | -236.80K | 771.00K | 1.09M | -1.71M | -1.01M |
| Capital Expenditure | -4.40K | -700.00 | -36.30K | -81.60K | -4.50K |
| Sale of Property, Plant, and Equipment | 18.30K | 25.60K | -- | -700.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -239.60K | -243.00K |
| Other Investing Activities | -310.90K | -365.40K | -392.40K | -682.10K | -696.30K |
| Cash from Investing | -296.90K | -340.60K | -428.70K | -1.00M | -943.90K |
| Total Debt Issued | 1.19M | -- | -- | 3.67M | 2.76M |
| Total Debt Repaid | -1.09M | -859.00K | -3.95M | -382.00K | -3.55M |
| Issuance of Common Stock | -- | 0.00 | 4.36M | 0.00 | -- |
| Repurchase of Common Stock | -20.00K | -- | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -252.00K | -298.00K | -354.00K | -103.00K | -264.00K |
| Cash from Financing | -128.30K | -845.50K | 36.30K | 2.34M | -791.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -662.10K | -415.10K | 693.50K | -376.30K | -2.75M |